Ironwood Pharmaceuticals reported 204.24 in PE Price to Earnings for its fiscal quarter ending in December of 2024.





Pe Change Date
Acadia Pharmaceuticals 9.52 1.81 Sep/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
Almirall 42.89 36.54 Jun/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
Amarin 91.05 88.3 Jun/2023
Astellas Pharma 9.57 0.16 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
Charles River Laboratories 27.69 30.58 Sep/2026
Emergent BioSolutions 14.4 2.25 Sep/2022
Halozyme Therapeutics 16.12 3.61 Sep/2026
Incyte 54.54 40.08 Sep/2026
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Moderna 27.22 14.51 Jun/2023
Pacira 80.9 45.22 Sep/2026
PTC Therapeutics 8.76 0 Jun/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Sarepta Therapeutics 32.09 22.66 Sep/2026
Takeda 21.04 3.36 Sep/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023